Drug Puts A $750,000 ‘Price Tag On Life’
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
The independent source for health policy research, polling, and news.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Mary Agnes Carey of Kaiser Health News discuss what happens now in the wake of the apparent demise of the Republican-only repeal and replace efforts for the Affordable Care Act.
By taking aim at the subsidies received by some congressional staff members who, under the Affordable Care Act, are mandated to get their health coverage from the Obamacare exchanges, the president reignited an old fight.
Only about a third of U.S. adults have advance directives in place to guide the care they receive in the event that they are unable to make their own decisions about life-sustaining medical treatments.
Tighter Medicaid budgets could jeopardize states’ home-based services that help older adults and disabled people live in their homes instead of more expensive nursing homes.
The Trump administration is poised to grant states waivers that some critics say could change the shape of the program.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Mary Agnes Carey of Kaiser Health News deconstruct the drama leading to the middle-of-the-night collapse of Senate Republicans’ last-ditch effort to overhaul the Affordable Care Act.
As postmortems mount regarding the collapse of the Senate Republican health plan, it’s clear how complex political and policy issues worked against the replacement effort.
The Trump administration has a variety of mechanisms at its disposal that could undermine the insurance exchanges.
The Trump administration has a variety of mechanisms at its disposal that could undermine the insurance exchanges.
The Affordable Care Act has repeatedly faced opposition in Congress and the courts, but it has continued to survive.
The Affordable Care Act has repeatedly faced opposition in Congress and the courts, but it has continued to survive.
After a late-night session and the “skinny” defeat, Senate Majority Leader Mitch McConnell pulls legislation to repeal the Affordable Care Act from the floor.
Sharing ministries are based on biblical principles and are not the same as commercial insurance. They are not legally binding and may not cover some common medical expenses.
The number of Americans with high-deductible health plans is growing, along with the fear that even insured people won’t get the care they need because it’s too costly.
A Wisconsin lawsuit alleges United Healthcare downplayed abusive sales tactics to avoid losing government bonuses.
Dr. Sanjay Mishra, the husband of CMS Administrator Seema Verma, is part of a group practice in Indiana that does not accept Medicaid payments.
Republican senators are warming to the idea of a scaled-back plan that would delete the Affordable Care Act’s individual and employer mandates but leave the rest of law generally intact. But this approach has caused difficulties in the past.
For pregnant women in the United States, Medicaid is less a safety net than a building block of the maternity care system.
The majority of older adults receive long-term care at home and need help covering these services with affordable insurance policies. The long-term insurance industry needs to focus on home care.
Subscribe to KFF Health News' free Morning Briefing.
Noticias en español
© 2026 KFF